Sign Up Today and Learn More About Immunophage Biotech Stock
Invest in or calculate the value of your shares in Immunophage Biotech or other pre-IPO companies through EquityZen's platform.
Immunophage Biotech Stock (IMMB)
Immunophage Biotech is a Nanjing-based pharmaceutic company.
About Immunophage Biotech Stock
Founded
2016
Industries
Messaging and Telecommunications, Content and Publishing, Sports
Immunophage Biotech Press Mentions
Stay in the know about the latest news on Immunophage Biotech
Methods and Compositions for Targeting Tregs using CCR8 Inhibitors
patents • Apr 02, 2025
Compounds and their uses as gpr183 inhibitors
patents • Feb 11, 2025
Compounds as inhibitors of macrophage migration inhibitory factor and the use …
patents • Feb 11, 2025
Anti-gpr183 antibodies and uses thereof
patents • Feb 11, 2025
Anti-CCR8 Antibodies and Uses Thereof
patents • Feb 11, 2025
Immunophage Biotech Management
Leadership team at Immunophage Biotech
Director of Clinical Medicine
Zhang Qi
Chief Scientific Officer
Jianfei Wang
Join now and verify your accreditation status to gain access to:
- Immunophage Biotech Current Valuation
- Immunophage Biotech Stock Price
- Immunophage Biotech Management
- Available deals in Immunophage Biotech and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Immunophage Biotech Cap Table and Funding History by Share Class and Liquidity Preferences
- Immunophage Biotech Revenue and Financials
- Immunophage Biotech Highlights
- Immunophage Biotech Business Model
- Immunophage Biotech Risk Factors
- Immunophage Biotech Research Report from SACRA Research
Trading Immunophage Biotech Stock
How to invest in Immunophage Biotech stock?
Accredited investors can buy pre-IPO stock in companies like Immunophage Biotech through EquityZen funds. These investments are made available by existing Immunophage Biotech shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Immunophage Biotech stock?
Shareholders can sell their Immunophage Biotech stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
